ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
13
views
0
references
Top references
cited by
147
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,843
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.
Author(s):
K G Tolman
,
Vivian Fonseca
,
Anthony Dalpiaz
,
Hongzhuan Tan
Publication date:
2007-02-28
Journal:
Diabetes Care
Keywords:
Benzamides
,
adverse effects
,
therapeutic use
,
Diabetes Mellitus, Type 2
,
classification
,
complications
,
therapy
,
Fatty Liver
,
Humans
,
Hypoglycemic Agents
,
Liver Diseases
,
Liver Function Tests
,
Safety
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
EPA CompTox Chemicals Dashboard
Author and article information
Journal
PubMed ID::
17327353
DOI::
10.2337/dc06-1539
ScienceOpen disciplines:
Chemistry
Keywords:
Benzamides
,
adverse effects
,
therapeutic use
,
Diabetes Mellitus, Type 2
,
classification
,
complications
,
therapy
,
Fatty Liver
,
Humans
,
Hypoglycemic Agents
,
Liver Diseases
,
Liver Function Tests
,
Safety
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Benzamides
,
adverse effects
,
therapeutic use
,
Diabetes Mellitus, Type 2
,
classification
,
complications
,
therapy
,
Fatty Liver
,
Humans
,
Hypoglycemic Agents
,
Liver Diseases
,
Liver Function Tests
,
Safety
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,843
Mutational Spectrum of MYO15A and the Molecular Mechanisms of DFNB3 Human Deafness.
Authors:
Atteeq Rehman
,
Jonathan E. Bird
,
Rabia Faridi
…
Disorder-specific grey matter deficits in attention deficit hyperactivity disorder relative to autism spectrum disorder
Authors:
C Lim
,
K. Chantiluke
,
A. Cubillo
…
A Systematic Review of the Spectrum of Cardiac Arrhythmias in Sub-Saharan Africa
Authors:
Matthew Yuyun
,
Aimé Bonny
,
G. Ng
…
See all similar
Cited by
143
Mechanisms of Insulin Action and Insulin Resistance
Authors:
Max Petersen
,
Gerald I. Shulman
Regulation of hepatic glucose metabolism in health and disease
Authors:
Max Petersen
,
Daniel Vatner
,
Gerald I. Shulman
The role of fatty acids in insulin resistance
Authors:
Barry Sears
,
Mary Perry
See all cited by